Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:alternativeName |
XMT-1536
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:contains |
monomethyl auristatin E (MMAE)
|
| gptkbp:developer |
gptkb:Mersana_Therapeutics
|
| gptkbp:drugClass |
gptkb:biotechnology
|
| gptkbp:investigatedBy |
gptkb:non-small_cell_lung_cancer
gptkb:cancer gptkb:endometrial_cancer solid tumors |
| gptkbp:mechanismOfAction |
delivers cytotoxic agent to PTK7-expressing cells
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:PTK7
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:ASP-1929
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
PTK7-ADC
|